Application of a new statistical approach to evaluate a clinical trial with panic disorder patients

被引:7
作者
Bandelow, B
Brunner, E
Beinroth, D
Pralle, L
Broocks, A
Hajak, G
Rüther, E
机构
[1] Univ Gottingen, Dept Psychiat, D-3400 Gottingen, Germany
[2] Univ Gottingen, Dept Med Stat, D-3400 Gottingen, Germany
关键词
panic disorder; agoraphobia; imipramine; self-exposure; rank test;
D O I
10.1007/s004060050061
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In clinical trials in psychiatry, changes in severity are usually measured with ordinal level scales which are applied repeatedly during the trial, showing a constant decline in psychopathology scores as treatment leads to improvement. Previous non-parametric tests for repeated measures in factorial designs did not test the hypothesis that scale scores decrease constantly during the trial. A recently developed "rank test for ordered alternatives in a mixed model" was developed and applied to the data of a clinical trial in panic disorder. Thirty-seven outpatients with panic disorder and agoraphobia (PDA) were treated with imipramine (75-150 mg/day) in an 8-week open, prospective trial. Patients with intercurrent agoraphobia were instructed in practising self-exposure in their agoraphobic situations. The total score on the Panic and Agoraphobia Scale, the Hamilton Anxiety Scale (HAMA) and the Clinical Global Impression Scale (CGI) were used as the main efficacy measures. The new rank test showed significant treatment results in all scales applied. Treatment results were excellent, as was shown by a decrease in the average Panic and Agoraphobia Scale severity scores from 28.9 (range 14-45) to 13.3 (range 0-37; rank statistic T-n = 6.7; p < 0.0001). The largest effect size r(w) of all clinician-rated scales was seen with the observer-rated version of the Panic and Agoraphobia Scale, although closely followed by the CGI and the MAMA. Among the self-rated scales, the Panic and Agoraphobia Scale also showed the largest effect size. All five subscores of the Panic and Agoraphobia Scale showed significant improvements. The highest treatment effect sizes were seen in the "panic attacks" subscore, followed by the "anticipatory anxiety" subscore. The new statistical test applied in this study, which has some advantages in comparison with previously applied tests, is suitable for psychiatric treatment evaluations since it can also be applied in the case of discrete repeated measurements.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 21 条
[1]   FULLY NONPARAMETRIC HYPOTHESES FOR FACTORIAL-DESIGNS .1. MULTIVARIATE REPEATED-MEASURES DESIGNS [J].
AKRITAS, MG ;
ARNOLD, SF .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1994, 89 (425) :336-343
[2]   A unified approach to rank tests for mixed models [J].
Akritas, MG ;
Brunner, E .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 1997, 61 (02) :249-277
[3]  
AKRITAS MG, 1996, RES DEV PROBABILITY, P277
[4]   ROLE OF EXPOSURE HOMEWORK IN PHOBIA REDUCTION - A CONTROLLED-STUDY [J].
ALKUBAISY, T ;
MARKS, IM ;
LOGSDAIL, S ;
MARKS, MP ;
LOVELL, K ;
SUNGUR, M ;
ARAYA, R .
BEHAVIOR THERAPY, 1992, 23 (04) :599-621
[5]   ASSESSING THE EFFICACY OF TREATMENTS FOR PANIC DISORDER AND AGORAPHOBIA .2. THE PANIC AND AGORAPHOBIA SCALE [J].
BANDELOW, B .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (02) :73-81
[6]   Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder [J].
Broocks, A ;
Bandelow, B ;
Pekrun, G ;
George, A ;
Meyer, T ;
Bartmann, U ;
Hillmer-Vogel, U ;
Rüther, E .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (05) :603-609
[7]   RANK STATISTICS UNDER DEPENDENT OBSERVATIONS AND APPLICATIONS TO FACTORIAL-DESIGNS [J].
BRUNNER, E ;
DENKER, M .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 1994, 42 (03) :353-378
[8]   THE MOBILITY INVENTORY FOR AGORAPHOBIA [J].
CHAMBLESS, DL ;
CAPUTO, GC ;
JASIN, SE ;
GRACELY, EJ ;
WILLIAMS, C .
BEHAVIOUR RESEARCH AND THERAPY, 1985, 23 (01) :35-44
[9]   DRUG-TREATMENT OF PANIC DISORDER - COMPARATIVE EFFICACY OF ALPRAZOLAM, IMIPRAMINE, AND PLACEBO [J].
COLEMAN, JH ;
KLERMAN, GL ;
AYUSO, JL ;
BECH, P ;
BENKERT, O ;
BRANDON, S ;
CASSANO, GB ;
SILVA, JACE ;
CURTIS, GC ;
DELAFUENTE, JR ;
GUIMON, J ;
HIPPIUS, H ;
LECRUBIER, Y ;
LEON, CA ;
LOPEZIBOR, JJ ;
KATSCHNIG, H ;
MASSANA, J ;
MELLERGAARD, M ;
OTTOSON, JO ;
RAFAELSEN, OJ ;
ROSENBERG, R ;
ROTH, M ;
SEPULVEDA, J ;
SOLYOM, L ;
VERSIANI, M ;
WILMOTTE, J .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :191-202
[10]  
CORYELL W, 1988, AM J PSYCHIAT, V145, P1138